|
|
| Line 14: |
Line 14: |
|
| |
|
| == 3D structures of ankyrin repeat domain-containing protein == | | == 3D structures of ankyrin repeat domain-containing protein == |
|
| |
| [[Ankyrin repeat domain-containing protein 3D structures]] | | [[Ankyrin repeat domain-containing protein 3D structures]] |
|
| |
|
| </StructureSection> | | </StructureSection> |
|
| |
|
| == 3D structures of ankyrin repeat domain-containing protein ==
| |
|
| |
| [[4nl9]] - hARDCP 3 SAM domain + hARDCP 14 SAM domain - human<br />
| |
| [[5ybj]] - hARDCP 15 residues 1080-1329<br />
| |
| [[5ybu]] - hARDCP 15 residues 1080-1329 + KIF21A peptide<br />
| |
| [[4hbd]] - hARDCP 25 residues 578-832<br />
| |
| [[6tmd]] - hARDCP 25 residues 583-832 (mutant)<br />
| |
| [[5ybv]] - hARDCP 25 residues 578-832 + KIF21A peptide<br />
| |
| [[4cym]] - hARDCP 27 residues 450-640 + RAB32<br />
| |
| [[4cz2]] - hARDCP 27 residues 450-640 + RAB32 + GPPCP<br />
| |
| [[4b93]] - hARDCP 27 residues 659-921 + VAMP7<br />
| |
| [[5wni]] - mARDCP 3 residues 1-342 - mouse<br />
| |
| [[5wnk]] - mARDCP 3 residues 1-342 (mutant)<br />
| |
| [[5wnj]], [[5wnm]] - mARDCP 3 residues 1-342 (mutant) + cancer drug<br />
| |
| [[5wnl]] - mARDCP 3 residues 1-342 (mutant) + staurosporine<br />
| |
| [[6nxf]] - mARDCP 31 C-terminal + REC114<br />
| |
| [[6tlh]] - mARDCP 47 residues 524-773 <br />
| |
| [[5eid]], [[4tum]] - AtARDCP 2 residues 211-342 - ''Arabidopis thaliana''<br />
| |
| [[6jd6]] - AtARDCP EMB56 + ARDCP<br />
| |
| [[7ubz]] – ARDCP residues 1-230 + lipase effector – ''Enterobacter cloacae''<br />
| |
|
| |
| == References ==
| |
| <references/> | | <references/> |
| [[Category:Topic Page]] | | [[Category:Topic Page]] |